Medications for Psoriasis Vulgaris

33 results

  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • bimzelx - bimekizumab injection, solution

    (Bimekizumab)
    Ucb, Inc.
    BIMZELX treats adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis with objective signs of inflammation, and moderate-to-severe hidradenitis suppurativa.
    Medication Details
    Drug Interactions

  • cimzia - certolizumab pegol

    (Certolizumab Pegol)
    Ucb, Inc.
    CIMZIA is a TNF blocker that treats moderately to severely active Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and plaque psoriasis in adults, and polyarticular juvenile idiopathic arthritis in patients 2 years and older.
    Medication Details
    Drug Interactions

  • cosentyx - secukinumab injection

    (Secukinumab)
    Novartis Pharmaceuticals Corporation
    Cosentyx treats moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and moderate-to-severe hidradenitis suppurativa in eligible adults and pediatric patients.
    Medication Details
    Drug Interactions

  • cyltezo - adalimumab - adbm

    (Adalimumab-Adbm)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Cyltezo is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis in adults, and juvenile idiopathic arthritis and uveitis in pediatric patients.
    Medication Details
    Drug Interactions

  • duobrii - halobetasol propionate and tazarotene lotion

    (Halobetasol Propionate And Tazarotene)
    Bausch Health Us, Llc
    Duobrii (halobetasol propionate and tazarotene) Lotion is indicated for the topical treatment of plaque psoriasis in adults.
    Medication Details
    Drug Interactions

  • enbrel - etanercept

    (Etanercept)
    Immunex Corporation
    Enbrel is a TNF blocker for adults with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis; and for children 2+ with polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis, and children 4+ with plaque psoriasis.
    Medication Details
    Drug Interactions

  • enstilar - calcipotriene and betamethasone dipropionate aerosol, foam

    (Calcipotriene And Betamethasone Dipropionate)
    Leo Pharma Inc.
    Enstilar foam treats plaque psoriasis topically in patients aged 12 and older. It combines calcipotriene and betamethasone dipropionate.
    Medication Details
    Drug Interactions